For children under one year old with infantile botulism, the available treatment is an intravenous medication called BabyBIG, which is produced from the blood plasma of people immunized against botulinum neurotoxins.
November 12, 2025
high
medical-treatment
Standard antitoxin therapy for infantile botulism in infants under 12 months.
The specific antitoxin treatment for infant botulism is BabyBIG (botulism immune globulin intravenous), an intravenous preparation derived from the blood plasma of people immunized against botulism.
November 11, 2025
high
treatment
Standard therapy for confirmed infant botulism
The only treatment for infant botulism is BabyBIG, an intravenous medication made from pooled blood plasma of adults immunized against botulism; BabyBIG was developed by California's Infant Botulism Treatment and Prevention Program and is the sole source worldwide, and it shortens hospital stays and decreases illness severity.
November 10, 2025
high
treatment
Approved therapy and its provenance and effects
BabyBIG is the only treatment for infant botulism; it is an intravenous medication made from pooled blood plasma of adults immunized against botulism and was developed by California's Infant Botulism Treatment and Prevention Program, which is the sole source worldwide.
high
treatment
Approved therapy and source for treating infant botulism